W STRATEGIES, LLC for GLAXOSMITHKLINE
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform. American Jobs and Closing Tax Loopholes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Taxation/Internal Revenue Code TAX
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform. American Jobs and Closing Tax Loopholes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Health Issues HCR
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform. American Jobs and Closing Tax Loopholes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Medicare/Medicaid MMM
Implementation of PPACA, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars. Patent Reform. American Jobs and Closing Tax Loopholes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX New | Asst for Policy, Speaker Dennis HastertAdmin Asst; Leg Dir; Leg Asst, Cong. Porter GossHouse Rules Comm Assoc, Subcomm Staff Dir. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GLAXOSMITHKLINE, PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.